Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19; and High Infection Risk of SARS-CoV-2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06057064
What this trial is testing

Study Will Assess the Safety, Neutralizing Activity and Efficacy of AZD3152 in Adults With Conditions Increasing Risk of Inadequate Protective Immune Response After Vaccination and Thus Are at High Risk of Developing Severe COVID-19

Who this might be right for
COVID-19, SARS-CoV-2
AstraZeneca 116
Not applicableActive Not RecruitingNCT05471011
What this trial is testing

COVID-19 Outcome Prediction Algorithm

Who this might be right for
COVID-19Post Acute Sequelae of COVID-19Long COVID+2 more
University of California, Los Angeles 600
Large-scale testing (Phase 3)UnknownNCT04836260
What this trial is testing

Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19

Who this might be right for
Covid19Immuno-DeficiencyOld Age; Debility
University Hospital, Geneva 100
Large-scale testing (Phase 3)Study completedNCT07069309
What this trial is testing

Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participants Ages ≥65 Years

Who this might be right for
COVID-19SARS-COV-2 Infection
BioNTech SE 774
Large-scale testing (Phase 3)Study completedNCT05459532
What this trial is testing

A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa

Who this might be right for
COVID-19
University of Witwatersrand, South Africa 59
Early research (Phase 1)UnknownNCT04462848
What this trial is testing

Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions

Who this might be right for
Corona Virus Infection
University of California, Los Angeles 30
Not applicableStudy completedNCT04366778
What this trial is testing

Thrombosis and Covid-19

Who this might be right for
ThrombosisCovid-19SARS-CoV 2
Hospices Civils de Lyon 341
Not applicableLooking for participantsNCT05425264
What this trial is testing

Home-Based Exercise Tele-Rehabilitation After COVID-19

Who this might be right for
Post SARS-CoV2 (COVID-19)
VA Office of Research and Development 80
Early research (Phase 1)Study completedNCT04377672
What this trial is testing

Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19)

Who this might be right for
SARS-CoV-2 Infection
Johns Hopkins University 14
Large-scale testing (Phase 3)UnknownNCT04425837
What this trial is testing

Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19

Who this might be right for
Sars-CoV2Covid-19
Fundación Santa Fe de Bogota 236
Not applicableUnknownNCT04604249
What this trial is testing

Prevalence of COVID-19 in High Altitude : Insights From the Highest City of the World

Who this might be right for
Covid19High Altitude
Centre d'Expertise sur l'Altitude EXALT 200
Not applicableStudy completedNCT04375501
What this trial is testing

Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic

Who this might be right for
Femoral Neck FracturesSARS-CoV 2
Barts & The London NHS Trust 442
Early research (Phase 1)Looking for participantsNCT07445971
What this trial is testing

A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19.

Who this might be right for
COVID -19COVID-19 (Prevention)
ModeX Therapeutics, An OPKO Health Company 80
Large-scale testing (Phase 3)Ended earlyNCT04389840
What this trial is testing

Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Acute Lung InjurySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Jazz Pharmaceuticals 27
Not applicableLooking for participantsNCT05890612
What this trial is testing

A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19

Who this might be right for
COVID-19
Pfizer 3,000
Not applicableUnknownNCT06255600
What this trial is testing

High-definition Transcranial Direct Current Stimulation and Chlorella Pyrenoidosa to Reduce Cardiovascular Risk

Who this might be right for
Cardiovascular DiseasesLong Covid19
Federal University of Paraíba 60
Early research (Phase 1)UnknownNCT04708327
What this trial is testing

Single-Blind Study of STAT-205 in Mild COVID-19

Who this might be right for
COVID-19
Cytocom, Inc. 24
Large-scale testing (Phase 3)WithdrawnNCT04684550
What this trial is testing

Use of Hypochlorous Acid as Prophylaxis in Health Personnel at High Risk of Infection by SARS-CoV 2 (COVID19)

Who this might be right for
SARS-CoV InfectionCovid19Infection Viral
Hospital Universitario San Ignacio
Testing effectiveness (Phase 2)WithdrawnNCT05393999
What this trial is testing

SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations

Who this might be right for
SARS-CoV2 InfectionSARS-CoV-2 Acute Respiratory DiseaseMyeloma+4 more
Imperial College Healthcare NHS Trust
Large-scale testing (Phase 3)WithdrawnNCT05157243
What this trial is testing

Trial to Evaluate Nitazoxanide for Treatment of Mild or Moderate COVID-19 in Subjects at High Risk of Severe Illness

Who this might be right for
COVID-19
Romark Laboratories L.C.
Next Page